OPEN

Post-Marketing Safety Concerns with Esketamine: A Disproportionality Analysis of Spontaneous Reports Submitted to the FDA Adverse Event Reporting System

Gastaldon, C., Raschi, E., Kane, J. M., Barbui, C., & Schoretsanitis, G. | Psychotherapy and psychosomatics | December 2020

By OPEN|2021-03-24T17:44:23+01:001 December 2020|Tags: C. Barbui, C. Gastaldon, E. Raschi, G. Schoretsanitis, J. Kane|

Neurocognitive impact of ketamine treatment in major depressive disorder: A review on human and animal studies – PubMed

Crisanti, C., Enrico, P., Fiorentini, A., Delvecchio, G., & Brambilla, P. | Journal of Affective Disorders | 1 November 2020

By OPEN|2021-08-07T23:04:35+02:001 November 2020|Tags: A. Fiorentini, C. Crisanti, G. Delvecchio, P. Brambilla, P. Enrico|

Phytochemical, Cytotoxicity, Antioxidant and Anti-Inflammatory Effects of Psilocybe Natalensis Magic Mushroom

Nkadimeng, S. M., Nabatanzi, A., Steinmann, C. M., & Eloff, J. N. | Plants | 31 August 2020

By OPEN|2021-03-24T17:38:00+01:0031 August 2020|Tags: A. Nabatanzi, C. Steinmann, J. Eloff, S. Nkadimeng|

Plasma psilocin critically determines behavioral and neurobiological effects of psilocybin

Madsen, M. K., & Knudsen, G. M. | Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology | 25 August 2020

By OPEN|2021-03-24T17:09:14+01:0025 August 2020|Tags: G. Knudsen, M. Madsen|

A low dose of lysergic acid diethylamide decreases pain perception in healthy volunteers

Ramaekers, J. G., Hutten, N., Mason, N. L., Dolder, P., Theunissen, E. L., Holze, F., ... & Kuypers, K. P. | Journal of Psychopharmacology | 25 August 2020

By OPEN|2021-03-24T17:14:39+01:0025 August 2020|Tags: E. Theunissen, F. Holze, J. Ramaekers, K. Kuypers, N. Hutten, N. Manson, P. Dolder|

Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies

Breeksema, J. J., Niemeijer, A. R., Krediet, E., Vermetten, E., & Schoevers, R. A | CNS drugs | 17 August 2020

By OPEN|2021-03-24T17:22:09+01:0017 August 2020|Tags: A. Niemeijer, E. Krediet, E. Vermetten, J. Breeksema, R. Schoevers|

The rise, fall, and possible rise of LSD

Snelders, S., & Pieters, T. |  Tijdschrift Voor Psychiatrie | August 2020

By OPEN|2021-03-08T18:47:29+01:001 August 2020|Tags: S. Snelders, T. Pieters|

[Psychedelics in the treatment of substance use disorders and psychosis]

van den Brink, W., Breeksema, J. J., Vermetten, E., & Schoevers, R. A. | Tijdschrift Voor Psychiatrie | 1 August 2020

By OPEN|2021-08-02T14:30:58+02:001 August 2020|Tags: E. Vermetten, J. Breeksema, R. Schoevers, W. van den Brink|

[Psychedelics for existential distress in terminally ill patients]

Schimmel, N., Breeksema, J. J., Veraart, J. K. E., van den Brink, W., & Schoevers, R. A. | Tijdschrift Voor Psychiatrie | 1 August 2020

By OPEN|2021-08-02T14:35:54+02:001 August 2020|Tags: J. Breeksema, J. Vervaart, N. Schimmel, R. Schoevers, W. van den Brink|

Microdosing with psychedelics: what do we know?

Kuypers, K. P. C. | Tijdschrift Voor Psychiatrie | 1 Augustus 2020

By OPEN|2021-08-07T23:09:55+02:001 August 2020|Tags: K. Kuypers|